Secure-IC's Securyzr™ Tunable Hash (SM3) Hardware accelerator
UMC Takes Bigger Slice of 28nm Business
Stands pat on capex
Alan Patterson, EETimes
10/29/2014 04:45 PM EDT
TAIPEI — UMC, the world’s third-largest chip foundry, said Wednesday, Oct. 29, that it has grabbed a larger piece of the 28 nanometer business that is dominated by Taiwan Semiconductor Manufacturing Company Ltd. (TSMC). UMC reiterated its capital expenditure for this year at about $1.3 billion.
UMC said that 28 nm products accounted for 3% of its foundry revenue during the third quarter this year, up from 1% during the previous quarter. The company expects continuing increases from the process technology during the rest of the year.
|
|
E-mail This Article |
|
Printer-Friendly Page |
|
||||||
Related News
- Siemens' Analog FastSPICE certified for UMC's 28nm HPCᵁ+ process technology
- USB, MIPI, Ethernet, DisplayPort, PCIe, DDR, HDMI, ONFi Analog Phy IP Cores silicon proven in UMC 28nm & UMC 40nm Process
- Faraday Unveils Complete Imaging and Display High-Speed Interface IP Set on UMC 28nm and 40nm Processes
- eMemory and UMC Qualify NeoFuse IP on the Foundry's 28nm High Voltage Process
- Arasan Chip Systems expands its storage IP Portfolio with ONFI 4.1 PHY and I/O PAD IP seamlessly integrated with its NAND Flash Controller IP for UMC 28nm SoC Designs
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






